Valar Labs
PrivateLast Round
Series A
May 30, 2024
Est. Valuation
$50.51M
Total Funding Raised
$26.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Valar Labs operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Series A round in May 2024.
Valar Labs is a healthcare technology company that develops AI-powered diagnostic tests to analyze tumor histology slides and provide actionable insights for precision oncology treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valar Labs Comparables
Compare Valar Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ArteraAI | 82% | |
| Cellens Inc. | 78% | |
| Tempus | 78% |
For institutional investors. Book with your work email.
Valar Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 30, 2024 | ||||
| Seed | Apr 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Valar Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed, Series A |
| Romulus Capital | Seed |
| Pear VC | Seed, Series A |
| Takura | Seed |
| Koa Labs | Seed |
| Martin Ventures | Seed |
| DCVC (Data Collective) | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 79% MoM, reaching 6.8K.
- Apr 1, 2022
$4.15M round led by Andreessen Horowitz.
For institutional investors. Book with your work email.
Valar Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Valar Labs's valuation, stock price, and market status.
Is Valar Labs a public or private company?
Valar Labs is a private company.
What is the current stock price of Valar Labs?
Valar Labs is a private company, so its shares have no public market price. Caplight tracks Valar Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Valar Labs worth (valuation)?
Valar Labs's valuation is estimated at $50.5M based on funding round data.
Can I buy Valar Labs stock?
Valar Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Valar Labs's last funding round?
Valar Labs's most recent funding round was Series A on May 30, 2024.
Who are the main investors in Valar Labs?
Key investors in Valar Labs include Andreessen Horowitz, DCVC (Data Collective).
Will Valar Labs IPO soon?
No public IPO plans have been announced for Valar Labs.
How can I track Valar Labs secondary market activity?
Caplight tracks bids, offers, and trades in Valar Labs's shares on secondary markets.